What is it about?
NK cells in AML patients show diminished expression of several activating receptors that contribute to impaired NK cell function and, in consequence, to AML blast escape from NK cell immunosurveillance.
Featured Image
Why is it important?
In AML patients, phenotypic changes in NK cells have been correlated with disease progression and survival. NK cell-based immunotherapy has emerged as a possibility for the treatment of AML patients. The understanding of age-associated alterations in NK cells is therefore necessary to define adequate therapeutic strategies in older AML patients.
Read the Original
This page is a summary of: Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?, Cancer Immunology Immunotherapy, June 2015, Springer Science + Business Media,
DOI: 10.1007/s00262-015-1720-6.
You can read the full text:
Resources
Contributors
The following have contributed to this page